secwatch.observer — SEC 8-K summary
======================================

Issuer:     Benitec Biopharma Inc. (BNTC)
CIK:        0001808898
Form:       8-K
Filed at:   2024-09-05T23:59:59+00:00
Accession:  0001193125-24-213348
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Benitec stockholders approve Nasdaq-related proposal and equity plan amendment at special meeting
--------------------------------------------------------------------------------

- 5,947,860 shares (58.97% of outstanding) present at August 29 special meeting.
- Proposal 1 (Nasdaq) approved: 5,868,978 for, 13,614 against, 168 abstain.
- Proposal 2 (amendment to 2020 Equity Plan) approved: 5,024,173 for, 232,406 against, 626,181 abstain.
- Adjournment proposal not presented due to sufficient votes for other proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808898/000119312524213348/0001193125-24-213348-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808898/000119312524213348/d868099d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-213348

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer